However, combining IL-13/STAT6 and YAP1 increases the sensitivity and accuracy of serum AFP, which again highlights the critical role played by variables in predicting HCC development in NASH. The gene discussed is STAT6; the disease is metabolic dysfunction-associated steatohepatitis.